P

Inventor

ELSNER JAN

US22 patents
⚠️ This page may combine multiple inventors who share the name “ELSNER JAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIGNAL PHARM LLC

13 patents
US9701643B2Jul 11, 2017

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC19 citations91
US10919865B2Feb 16, 2021

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC3 citations83
US10266500B2Apr 23, 2019

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC5 citations83
US10040770B2Aug 7, 2018

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC7 citations83
US9771371B2Sep 26, 2017

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

SIGNAL PHARM LLC4 citations83
US8907087B2Dec 9, 2014

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

SIGNAL PHARM LLC4 citations83
US9079900B2Jul 14, 2015

Methods of synthesis and purification of heteroaryl compounds

SIGNAL PHARM LLC5 citations82
US11325890B2May 10, 2022

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC2 citations72
US10167290B2Jan 1, 2019

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

SIGNAL PHARM LLC1 citations72
US11292796B2Apr 5, 2022

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

SIGNAL PHARM LLC0 citations62
US12129237B2Oct 29, 2024

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

SIGNAL PHARM LLC0 citations61
US10683298B2Jun 16, 2020

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

SIGNAL PHARM LLC0 citations51
US9193692B2Nov 24, 2015

Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors

SIGNAL PHARM LLC0 citations51

PERRIN-NINKOVIC SOPHIE

3 patents

SIGNAL PHARMACEUTICAL LLC

3 patents

BENNETT BRYDON L

1 patent

HARRIS ROY L

1 patent

BAHMANYAR SOGOLE

1 patent